'Recruitment of 300 PC patients in 2 years.' - I don't think so.
20 pts in two years for the initial safety study would be about right. Plus the 52 weeks post last recruitment, would put a data point into 2020.
I'd like to see any evidence of a radioactive implantable medical device being able to recruit for a phase 1 at much above the 20/50 in a two year period.
OSL Price at posting:
13.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)